Is China Biotech Services stock a buy?

Yes, China Biotech Services pays dividends. Last time was Thursday 15th of June 2023 where the investors holding the stock on Friday 19th of May 2023 were paid HKD0.01 per share. Over the last 2 times between 2004 and 2023, China Biotech Services has paid HKD0.0179 with an average of HKD0.01 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for China Biotech Services 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.360, you would have made a loss of HKD-1.090 per share or -80.15%

No, the average daily trading liquidity for China Biotech Services is HKD227 822 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

China Biotech Services has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.92, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for China Biotech Services to be medium [0.55 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.